IL17A and head and neck squamous cell carcinoma: Draining lymph node cells showed an increased release of IL-17, known to promote HNSCC, in both CD3/CD28 and IR antigen stimulation conditions in the LY2 but not in the MOC2 HNSCC model (Figure 5F).